CHARLES RIVER LABORATORIES INTERNATIONAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.61 USD | +2.21% |
|
+5.67% | -15.99% |
EPS & Dividend: Charles River Laboratories International, Inc.
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 5.07 | 7.2 | 7.6 | 9.48 | 9.22 | 6.292 | 8.068 | 10.15 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 151.84 | 248.59 | 375.88 | 217.90 | 236.40 | 198.61 | 198.61 | 198.61 |
| Nbr of stocks (in thousands) | 48,839 | 49,743 | 50,464 | 50,879 | 51,297 | 51,631 | - | - |
| Announcement Date | 2/11/20 | 2/17/21 | 2/16/22 | 2/22/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: Charles River Laboratories International, Inc.
| 2024-10-29 | Q3 2024 Earnings Release (Projected) |
| 2025-02-11 | Q4 2024 Earnings Release (Projected) |
| 2025-05-07 | Q1 2025 Earnings Release (Projected) |
| 2025-07-29 | Q2 2025 Earnings Release (Projected) |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | 31.57x | 2.586 | 3.07x | ||
| +0.83% | +0.97% | 48.04x | 4.150 | 6.43x | ||
| -.--% | -.--% | 30.98x | 6.219 | 3.57x | ||
| -.--% | -.--% | -109.49x | 127.55 | 14.73x | ||
| +0.26% | +0.26% | 76.08x | 2.405 | 11.54x | ||
| -.--% | -.--% | -7.17x | 2.537 | 6.1x | ||
| -.--% | -.--% | 32.44x | 2.472 | 3.19x | ||
| -.--% | -.--% | 13.7x | 2.029 | 4.51x | ||
| +0.43% | +0.45% | 62.15x | 5.076 | 9.66x | ||
| -.--% | -.--% | 30.35x | 11.43 | 4.75x | ||
| Average | +0.15% | +0.17% | 20.87x | 16.65 | 6.75x | |
| Weighted average by Cap. | +0.20% | +0.23% | 17.35x | 20.66 | 7.14x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews